ReviewFrontiers in neurology2019

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings.

Krista Barclay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.